The proteomics of positron emission tomography
- 20 February 2004
- journal article
- editorial
- Published by Wiley in Annals of Neurology
- Vol. 55 (3) , 303-305
- https://doi.org/10.1002/ana.20053
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic miceProceedings of the National Academy of Sciences, 2003
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer DiseaseAmerican Journal of Geriatric Psychiatry, 2002
- Positron Emission Tomography in Evaluation of DementiaJAMA, 2001
- Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortexAnnals of Neurology, 2000
- Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography studyAnnals of Neurology, 2000
- Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 1999
- Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's diseaseThe Lancet, 1997
- Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein ENew England Journal of Medicine, 1996